Skip to content
Screener

Eikon Therapeutics, Inc. EIKN Market capitalization

Market capitalization at other companies

Gilead Sciences logo
Gilead SciencesGILD
$156.86B+17.6%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$2.93B+104%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$982.03M+385%
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
$178.25M-2.0%
Immunome logo
ImmunomeIMNM
$2.47B+323%
Erasca, Inc. logo
Erasca, Inc.ERAS
$5.03B+1,196%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M—
Total equity$550.7M+186%
Total assets$850.8M—

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Enterprise value$592.29M—

Returns & leverage

See full
Debt / equity0.5×—
Current ratio11.8×—

FAQ

What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.